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Abstract.  P-cadherin is a  subclass of Ca2+-dependent 
cell-cell adhesion molecules present in mouse 
placenta,  where its localization suggests a  function of 
connecting the embryo to the uterus (Nose,  A., and 
M.  Takeichi.  1986.  J.  Cell Biol.  103:2649-2658).  We 
recently identified a  human cadherin detected by an 
mAb capable of disrupting cell-cell adhesion of A-431 
cells, and found that it was closely related immuno- 
chemically to mouse P-cadherin.  Curiously, this 
cadherin was undetectable in human placenta by 
immunohistochemical examination (Shimoyama, Y., 
S.  Hirohashi, S.  Hirano, M.  Noguchi, Y.  Shimosato, 
M. Takeichi, and O.  Abe.  1989.  Cancer Res. 
49:2128-2133).  We here report the cloning and se- 
quencing of a  cDNA clone encoding the human homo- 
logue of mouse P-cadherin.  The deduced amino acid 
sequence of the human P-cadherin consists of 829 
amino acids and shows striking homology with mouse 
P-cadherin.  On Northern blot analysis, human P-cad- 
herin was scarcely expressed in human placenta in 
contrast to mouse P-cadherin, which was abundantly 
expressed in mouse placenta throughout pregnancy, 
and it was shown that E-cadherin, but not P-cadherin, 
was the major cadherin molecule in human placenta. 
Moreover, NIH3T3 cells transfected with human 
P-cadherin cDNA expressed the functional cadherin 
molecule, which was identical to the cadherin we had 
previously identified using the mAb, showing that this 
molecule really does mediate cell-cell adhesion and 
that the cadherin we detected immunochemically is 
undoubtedly human P-cadherin.  The results obtained 
in this study support the idea that P-cadherin plays lit- 
tle role, if any, in Ca2+-dependent cell-cell binding in 
human placental tissue at least after several weeks of 
pregnancy. 
C 
ADHERINS are integral membrane glycoproteins re- 
sponsible for Ca2+-dependent  cell-cell adhesion. At 
present it is known that they constitute a gene family 
consisting of at least three subclasses,  E-,  N-,  and P-cad- 
herin. In developing embryos, each subclass shows a unique 
spatiotemporal pattern of expression that coincides with the 
movement and rearrangement of cell collectives, suggesting 
that cadherins play a key role in morphogenetic events (for 
review,  see reference 22).  Recent studies using cells trans- 
fected with cadherin cDNAs have demonstrated experimen- 
tally  that  cadherin  molecules  are  directly  involved  in 
ceU-ceU binding (2, 15), and that they can control cell sort- 
ing in vitro (18). Their cell-cell binding function is mediated 
not by a ligand-receptor complex but occurs in a homophilic 
manner (2) in cooperation with certain cytoskeletal compo- 
nents (15). 
We  recently  reported  the  establishment  of two  mAbs 
recognizing two human cadherins, which are distinct from 
each other in terms of immunological specificity, molecular 
weight, and tissue distribution (20).  One of them showed a 
broad spectrum of expression in epithelial tissues with few 
exceptions, and was subsequently identified  as human E-cad- 
herin, which is possibly identical to cell-CAM 120/80  (1). 
In contrast, the tissue distribution of the other cadherin was 
very unique, being detected immunohistochemically in stra- 
tiffed epithelia only, and not in simple epithelia.  Even in 
stratified epithelia, this cadherin showed a characteristic ex- 
pression pattern:  it was detected in the basal or parabasal 
layers but not in the upper layers, suggesting a close relation- 
ship  with  differentiation. Since  the  purified extracellular 
fragments of this molecule showed specific cross-reactivity 
with anti-mouse P-cadherin sera raised in rabbit, this mole- 
cule was defined as human P-cadherin. P-cadherin was origi- 
nally identified in mouse placenta (16), and no data are avail- 
able  on  its  homologues  in  other  species.  Unexpectedly, 
however, the molecule defined as human P-cadherin by the 
mAb  was  immunohistochemically undetectable in human 
placental tissues despite the strong expression of E-cadherin. 
Therefore, the possibility remained that this molecule was 
P-related cadherin and distinct from authentic human P-cad- 
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P-cadherin cDNA to examine the expression of human P-cad- 
herin in human placenta and to elucidate whether the mole- 
cule identified by the mAb was, in fact, human P-cadherin. 
Materials and Methods 
Cell Cultures 
Vulvar epidermoid carcinoma A-431  cells, which coexpress P- and E-cad- 
herin (20), were cultured in DME supplemented with 10%  FCS at 370C in 
a humidified atmosphere containing 5% CO2/95% air. NIH3T3 cells were 
maintained in DME supplemented with  10%  calf serum under the same 
conditions as those above. 
Construction and Screening of  cDNA Library 
Poly(A)+RNA was isolated from A-431  cells as described by Maniatis et 
al. (12).  Double-stranded eDNA was synthesized using a cDNA synthesis 
system (Bethesda Research Laboratories, Gaithersburg, MD) according to 
the manufacturer's instructions followed by methylation of the Eco RI site 
and ligation to the arms of bacteriophage hgtl0 using Eco RI linkers (8). The 
recombinant phages were packaged in vitro using a ~, in vitro packaging kit 
(Amersham, UK), and then plated onto Escherichia coli strain NM514. The 
phage DNAs were transferred onto nylon filters. The filters were hybridized 
at 42°C in a buffer containing 50% formamide, 0.65 M  NaCI and a 5' Eco 
RV fragment of mouse P-cadherin eDNA (17)  labeled with [ot-32p]dCTP 
by random priming, washed at 65°C in 0.1  x  SSC/0.1% SDS, and exposed 
to film (XAR; Eastman Kodak Co., Rochester, NY) at  -70°C with inten- 
sifying screens. Positive plaques were picked  up and purified under the 
same conditions as those above. 
DNA Sequence Analysis 
A  human P-cadherin cDNA  was cloned  into the  Eco  RI  site of phage 
Ml3mpl8, and overlapping subclones were prepared by the stepwise dele- 
tion method (25). The nucleotide sequence was determined by the dideoxy 
chain-termination method (19) using a 370A DNA sequencer (Applied Bio- 
systems, Foster City, CA) as reported previously (5). Deoxy-7-deazaguano- 
sine triphosphate and sequenase (United States Biochemical Corp., Cleve- 
land, OH) were used in place of dGTP and Klenow fragment, respectively. 
DNA sequencing was performed in full for both strands. Nucleotide and 
amino acid sequences were analyzed using GENETYX programs (Software 
Development Co. Ltd., Tokyo, Japan) for a microcomputer and the IDEAS 
programs (10)  for a  VAX/VMS computer. 
Plasmid Construction 
For the expression of human P-cadherin in NIH3T3 cells, an expression vec- 
tor, p/3act-hP,  which contains the chicken/3 actin promoter upstream from 
the human P-cadherin eDNA fragment, was constructed from p/3act-CA'l-9 
(3). The human P-cadherin cDNA fragment, which contains the entire open 
reading frame and has the Hind llI-Eco RI sequence of the multicloning 
site of M13mpl8 and an Eco RI linker at its 5' end,  was obtained  from 
Ml3mpl8 containing the cDNA in its Eco RI site by double digestion with 
Hind III and Stu I. To generate p/$act-hP,  the Hind III-Hpa I fragment en- 
coding the CAT gene of p/$act-CAT9  was replaced with this Hind III-Stu 
I  fragment of human P-cadherin cDNA. 
Transfection 
Transfection of human P-cadherin cDNA into NIH3T3 cells was performed 
by calcium-phosphate coprecipitation  (24)  using 30/zg  of salmon testis 
DNA, 2/zg of p~act-hE and 0.2/zg of pSTneoB (11) per 1  x  106 cells in 
a  100-mm plastic dish.  At 8  h  after the addition of DNAs, the culture 
medium was replaced with fresh medium. The cells were cultured for an- 
other 12 h, and then transferred to other dishes in DME plus 10% calf serum 
with (3418 at 0.4 mg/ml. After •2  wk of culture, G418-resistant colonies 
were isolated, and examined for their reactivities with mAb NCC-CAD- 
299. Positive cells were then recloned. Transfectants were maintained in the 
above medium with G418 under the same conditions as those for NIH3T3 
cells. 
Antibody 
NCC-CAD-299 mAb, which recognizes a human cadherin closely related 
to mouse P-cadberin, was produced in ascitic fluid of mice inoculated in- 
traperitoneally  with  its hybridomas (20).  The  ascitic fluid  was diluted 
1:1,000,  and used as a  primary  antibody  for  immunocytochemistry and 
Western blot analysis. The antibody was purified by an Afli-Gel Protein A 
MAPS I1 kit (Bio-Rad Laboratories, Richmond, CA), and used for functional 
testing against transfectants of NIH3T3 cells expressing human P-cndherin. 
Immunocytochemistry 
Cells cultured on chamber slides (Nunc, Roskilde, Denmark) were rinsed 
with a  buffer containing 10 mM Hepes (pH 7.4),  150 mM NaCl, 2  mM 
CaCI2 (HNC), fixed with isopropanol for 10 rain at 4oc, and air dried. Af- 
ter rinsing with HNC, the samples were treated with 2%  swine serum in 
HNC (SS-HNC) for 30 min at room temperature, and then incubated with 
mAb NCC-CAD-299 overnight at 4°C. After washing with HNC and brief 
rinsing with SS-HNC, the samples were incubated with biotinylated anti- 
mouse IgG (Vector Laboratories Inc., Burlingame, CA) diluted 1/200 with 
SS-HNC for 30 min at room temperature. After washing with HNC, the 
samples were incubated with avidin-biotin-peroxidase complex (ABC; Vec- 
tor Laboratories, Inc.) diluted 1:100 with HNC for 30 min at room tempera- 
ture. After extensive washing with HNC, they were then stained with di- 
aminobenzidine, and counterstained with hematoxylin. 
Western and Northern Blot Analyses 
Western blot analysis was performed as described previously (20) except 
that diluted ascitic fluid was used as the primary antibody. Extraction of 
poly(A)+RNAs and Northern blot analysis were performed essentially as 
described by Maniatis et al.  (12).  Poly(A)+RNAs (2/~g/lane) were sepa- 
rated  in 0.9%  agarose/formaldehyde gels, transferred onto nitrocellulose 
filters, and hybridized at 42"C in a buffer containing 50% formamide and 
0.65 M  NaCI with probes labeled with [t~-32p]dCTP  by random priming. 
Probes used in this study were a 0.6-kb Sac I fragment of Map23 eDNA for 
the detection of human P-cadherin mRNA, a 0.8-kb Hinc II fragment of 
mouse P-cadherin eDNA (17) for mouse P-cadherin, and a 0.6-kb Eco RI 
fragment of mouse E-cadherin eDNA (15) for human and mouse E-cadberin. 
Each probe mainly consisted of the 5' noncoding exon of each eDNA to 
avoid crosshybridization with mRNAs of different subclasses. The filters 
were washed at 65°C in 0.1  x  SSC/0.1% SDS for human P-, mouse P- and 
E-cadherin, or at 52°C in 2  x  SSC/20 mM sodium phosphate buffer/0.06% 
sodium pyrophosphate/0.05% SDS for human E-cadberin. The RNA blot 




The ~,gtl0 cDNA library constructed from A-431 poly(A)  ÷ 
RNA was screened with the mouse P-cadherin probe. Ap- 
proximately 10  s recombinants were screened, and 41 posi- 
tive plaques were identified. These were then purified and 
examined for their cDNA  inserts.  One  clone,  designated 
)~hP23, contained a cDNA insert of ,o3.2 kb, which was al- 
most identical in size to human P-cadherin mRNA predicted 
from preliminary Northern blot analysis using a mouse P-cad- 
herin probe (data not shown). Moreover, this insert appeared 
to hybridize with the  same band  as the mouse P-cadherin 
probe on Northern blot analysis (data not shown). This eDNA 
was cloned into the Eco RI site of M13mp18 in both directions 
for the following sequence analysis. 
cDNA and Deduced  Amino Acid Sequences 
The nucleotide sequence and restriction endonuclease map of 
1. Abbreviations used in thispaper: HNC,  10 mM Hepes (pH 7.4), 150 mM 
NaCI, 2  mM CaCI2; SS-HNC, 2%  swine serum in HNC. 
The Journal of Cell  Biology, Volume 109,  1989  1788 GCGGAACACC GGCCCGCCGT CGCGGCAGCT GCTTCACCCC TCTCTCTGCA GCCATGGGGC TCCCTCGTGG ACCTCTCGCG TCTCTCCTCC TTCTCCAGGT  lO0 
TTGCTGGCTG CAGTGCGCGG CCTCCGAGCC GTGCCGGGCG  GTCTTCAGGG AGGCTGAAGT GACCTTGGAG GCGGGAGGCG  CGGAGCAGGA GCCCGGCCAG  200 
GCGCTGGGGA  AAGTATTCAT  GGGCTGCCCT GGGCAAGAGC CAGCTCTGTT TAGCACTGAT AATGATGACT TCACTGTGCG GAATGGCGAG ACAGTCCAGG  300 
AAAGAAGGTC ACTGAAGGAA AGGAATCCAT TGAAGATCTT CCCATCCAAA CGTATCTTAC GAAGACACAA GAGAGATTGG GTGGTTGCTC CAATATCTGT  400 
CCCTGAAAAT GGCAAGGGTC CCTTCCCCCA GAGACTGAAT CAGCTCAAGT CTAATAAAGA  TAGAGACACC AAGATTTTCT  ACAGCATCAC GGGGCCGGGG  500 
GCAGACAGCC CCCCTGAGGG TGTCTTCGCT GTAGAGAAGG AGACAGGCTG GTTGTTGTTG AATAAGCCAC TGGACCGGGA GGAGATTGCC AAGTATGAGC  600 
TCTTTGGCCA CGCTGTGTCA GAGAATGGTG CCTCAGTGGA GGACCCCATG AACATCTCCA  TCATCGTGAC CGACCAGAAT GACCACAAGC CCAAGTTTAC  700 
CCAGGACACC TTCCGAGGGA GTGTCTTAGA GGGAGTCCTA CCAGGTACTT CTGTGATGCA GGTGACAGCC ACAGATGAGG ATGATGCCAT CTACACCTAC  800 
AATGGGGTGG  TTGCTTACTC CATCCATAGC CAAGAACCAA  AGGACCCACA CGACCTCATG TTCACAATTC  ACCGGAGCAC AGGCACCATC AGCGTCATCT  900 
CCAGTGGCCT GGACCGGGAA AAAGTCCCTG AGTACACACT GACCATCCAG GCCACAGACA TGGATGGGGA CGGCTCCACC ACCACGGCAG TGGCAGTAGT  ]000 
GGAGATCCTT GATGCCAATG ACAATGCTCC CATGTTTGAC CCCCAGAAGT ACGAGGCCCA TGTGCCTGAG AATGCAGTGG GCCATGAGGT GCAGAGGCTG  ]]00 
ACGGTCACTG ATCTGGACGC CCCCAACTCA  CCAGCGTGGC GTGCCACCTA CCTTATCATG GGCGGTGACG ACGGGGACCA TTTTACCATC  ACCACCCACC  ]200 
CTGAGAGCAA CCAGGGCATC CTGACAACCA GGAAGGGTTT GGATTTTGAG GCCAAAAACC AGCACACCCT GTACGTTGAA GTGACCAACG AGGCCCCTTT  ]300 
TGTGCTGAAG CTCCCAACCT CCACAGCCAC CATAGTGGTC CACGTGGAGG ATGTGAATGA GGCACCTGTG TTTGTCCCAC CCTCCAAAGT CGTTGAGGTC  ]400 
CAGGAGGGCA TCCCCACTGG GGAGCCTGTG TGTGTCTACA CTGCAGAAGA CCCTGACAAG GAGAATCAAA  AGATCAGCTA CCGCATCCTG AGAGACCCAG  1500 
CAGGGTGGCT  AGCCATGGAC CCAGACAGTG GGCAGGTCAC AGCTGTGGGC ACCCTCGACC GTGAGGATGA GCAGTTTGTG AGGAACAACA TCTATGAAGT  ]600 
CATGGTCTTG GCCATGGACA ATGGAAGCCC TCCCACCACT GGCACGGGAA CCCTTCTGCT AACACTGATT  GATGTCAACG ACCATGGCCC AGTCCCTGAG  1700 
CCCCGTCAGA TCACCATCTG CAACCAAAGC CCTGTGCGCC ACGTGCTGAA CATCACGGAC AAGGACCTGT CTCCCCACAC CTCCCCTTTC CAGGCCCAGC  1800 
TCACAGATGA CTCAGACATC TACTGGACGG CAGAGGTCAA CGAGGAAGGT GACACAGTGG TCTTGTCCCT GAAGAAGTTC CTGAAGCAGG ATACATATGA  ]900 
CGTGCACCTT TCTCTGTCTG ACCATGGCAA CAAAGAGCAG CTGACGGTGA TCAGGGCCAC TGTGTGCGAC TGCCATGGCC ATGTCGAAAC CTGCCCTGGA  2000 
CCCTGGAAAG GAGGTTTCAT CCTCCCTGTG CTGGGGGCTG TCCTGGCTCT GCTGTTCCTC CTGCTGGTGC TGCTTTTGTT GGTGAGAAAG AAGCGGAAGA  2]00 
TCAAGGAGCC CCTCCTACTC CCAGAAGATG ACACCCGTGA CAACGTCTTC TACTATGGCG AAGAGGGGGG  TGGCGAAGAG GACCAGGACT ATGACATCAC  2200 
CCAGCTCCAC CGAGGTCTGG AGGCCAGGCC GGAGGTGGTT CTCCGCAATG ACGTGGCACC AACCATCATC CCGACACCCA TGTACCGTCC TAGGCCAGCC  2300 
AACCCAGATG AAATCGGCAA CTTTATAATT  GAGAACCTGA AGGCGGCTAA CACAGACCCC ACAGCCCCGC CCTACGACAC CCTCTTGGTG TTCGACTATG  2400 
AGGGCAGCGG  CTCCGACGCC GCGTCCCTGA GCTCCCTCAC CTCCTCCGCC TCCGACCAAG ACCAAGATTA  CGATTATCTG AACGAGTGGG GCAGCCGCTT  2500 
CAAGAAGCTG GCAGACATGT ACGGTGGCGG GGAGGACGAC TAGGCGGCCT GCCTGCAGGG CTGGGGACCA AACGTCAGGC CACAGAGCAT~CTCCAAGGGG  2600 
TCTCAGTTCC CCCTTCAGCT GAGGACTTCG GAGCTTGTCA GGAAGTGGCC GTAGCAACTT GGCGGAGACA GGCTATGAGT CTGACGTTAG AGTGGTTGCT  2700 
TCCTTAGCCT TTCAGGATGG AGGAATGTGG GCAGTTTGAC TTCAGCACTG AAAACCTCTC  CACCTGGGCC AGGGTTGCCT CAGAGGCCAA GTTTCCAGAA  2800 
GCCTCTTACC TGCCGTAAAA TGCTCAACCC TGTGTCCTGG GCCTGGGCCT GCTGTGACTG ACCTACAGTG GACTTTCTCT CTGGAATGGA ACCTTCTTAG  2900 
GCCTCCTGGT GCAACTTAAT TTTTTTTTTT  AATGCTATCT TCAAAACGTT AGAGAAAGTT CTTCAAAAGT GCAGCCCAGA GCTGCTGGGC CCACTGGCCG  3000 
TCCTGCATTT CTGGTTTCCA GACCCCAATG CCTCCCATTC GGATGGATCT CTGCGTTTTT ATACTGAGTG TGCCTAGGTT GCCCCTIATT TTTTATTTTC  3100 
CCTGTTGCGT TGCTATAGAT GAAGGGTGAG GACAATCGTG TATATGTACT AGAACTTTTT  TATTAAAGAA  A  3171 
Figure  1.  Nucleotide  sequence  of 
~,hP23  cDNA.  The  initiation  and 
stop codons are underlined. The bro- 
ken underlining indicates a polyade- 
nylation signal. 
hhP23 cDNA are shown in Figs.  1 and 2, respectively. MAP23 
contains an insert consisting of 3,171 nucleotides, which show 
77.0%  homology  with  the  nucleotide  sequence  of mouse 
P-cadherin cDNA (17). The open reading frame begins with 
an ATG codon at positions 54-56, terminates at a TAG codon 
at positions 2541-2543, and contains 2,487 nucleotides that 
correspond to 829 amino acids. Although no poly(A) tail is 
present in MAP23, a polyadenylation signal (ATTAAA), which 
is common to other cadherins reported so far (6,  15,  17), is 
identified at positions 3162-3167. 
The deduced amino acid sequence of the polypeptide en- 
coded by MAP23 cDNA as compared with that of mouse P-cad- 
herin (17) is shown in Fig. 3. This protein, like mouse P-cad- 
herin, has two hydrophobic regions that are considered to be 
signal and transmembrane sequences, and four cysteine resi- 
dues in the extracellular domain that are conserved among 
the cadherin family. A major internal repeat found in mouse 
P-cadherin (17) is also observed, and three out of four possi- 
ble NH2-1inked glycosylation sites of mouse P-cadherin are 
conserved in human P-cadherin.  Homologies between the 
protein encoded by ;khP23 cDNA (MAP23 protein) and cad- 
herins that have been sequenced so far are shown in Fig. 4. 
The  hhP23  protein  is  strikingly homologous with  mouse 
P-cadherin; homology between the two proteins is 82% for 
the whole sequence and 87 % for the putative mature protein. 
Homologies for the putative mature form between the hhP23 
protein and mouse E-cadherin (15), chicken L-CAM (4, 21), 
which is considered to be chicken E-cadherin, and chicken 
N-cadherin (6) are lower, 58%, 58%, and 47%, respectively. 
Moreover, the precursor region of the MAP23 protein is far 
diversified from that of mouse E-cadherin, chicken L-CAM 
or chicken N-cadherin (Fig. 4). Human uvomorulin or cell- 
CAM  120/80 is considered to be human E-cadherin,  and 
is the only human cadherin molecule for which sequences 
have been reported (13, 23). In the 155 amino acid sequences 
of human uvomorulin that have been determined (23), there 
is only 67 % homology with the khP23 protein, whereas in 
the corresponding sequences homology between the )~hP23 
protein and mouse P-cadherin is 88 %. These data strongly 
suggest that khP23 cDNA encodes human P-cadherin. 
mRNA Expression of P- and E-cadherin in Placenta 
Although P-cadherin has been shown to be involved in the 
function of mouse placenta (16), its probable human homo- 
logue was  not detected immunohistochemically in human 
placenta in contrast to the strong expression of E-cadherin 
(20). In this study, we examined the mRNA expression of  hu- 
man P- and E-cadherin in placenta as compared with those 
of mouse. Fig. 5 represents the mRNA expression of human 
P- (Fig. 5 a) and E-cadherin (Fig. 5 b). Human P-cadherin 
mRNA was detected as a single band, with an approximate 
molecular size of 3.2  kb,  in poly(A)+RNA  isolated from 
A-431 cells but not in placental  poly(A)+RNAs after exposure 
for 12 h (Fig. 5 a, lanes 1-5). When the filter was exposed 
PP  Sa  Sa  P  St 
#  Jl  J, 
!  I 
lkb 
Figure 2. Restriction endonuclease map of hhP23 cDNA. The open 
reading frame is shown as a clear Ix)×. P, Pst I; Sa, Sac I; A, Acc 
I; H, Hinc II; St, Stu I. 
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Figure 3. Comparison of amino acid 
sequences of the protein encoded by 
AhP23  eDNA  (upper)  and  mouse 
P-cadherin (lower)  (17). Conserved 
residues  are  marked  by  asterisks. 
The putative signal peptide and trans- 
membrane regions are indicated by 
bold lines. The NH2 terminus of the 
mature protein predicted from data 
on other cadherins is indicated by a 
vertical line. The major internal re- 
peats and possible NH2-1inked gly- 
cosylation  sites  are  shown  by  ar- 
rows  and  arrowheads,  respectively. 
The four cysteine residues conserved 
among the cadherin family are marked 
by rhombi. 
for 5 d, a faint band appeared at a position of ,03.2 kb even 
in poly(A)+RNAs of early-stage placenta  (Fig.  5  a,  lanes 
6-8). However, human E-cadherin mRNA, ,04.5 kb in size, 
was  clearly detected in poly(A)+RNAs isolated from both 
A-431 cells and placental tissues at 8 to 11 wk of pregnancy 
(Fig.  5 b).  These results are consistent with the immuno- 
histochemical data previously reported (20). In mouse pla- 
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Figure  4.  Homologies between  the  protein en- 
coded by XhP23cDNA and other cadherins in sep- 
arate regions, whole protein and putative mature 
protein. The extracellular  domain was divided into 
5 regions according to Hatta et al. (6). mP (e), hU 
([]),  mE (o),  cL (zx), and cN (A)  represent per- 
centage homology between the protein encoded 
by  hhP23cDNA  and  mouse  P-cadherin,  human 
uvomorulin  (cell-CAM  120/80),  mouse  E-cad- 
herin, chicken L-CAM, and chicken N-cadherin, 
respectively. The sequence data for human uvo- 
morulin  (cell-CAM  120/80)  are  only  partially 
available at present (13, 23). S, signal peptide; P, 
precursor region; EC, extraceilular domain; TM, 
transmembrane domain; IC, intmcellular domain; 
WP, whole protein; MP, mature protein. 
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sis of poly(A)+RNAs isolated 
from human  carcinoma cells 
and  placenta.  (a)  Poly(A)  + 
RNAs from A-431 cells (lane 
1),  and human placenta at 8 
(lanes 2  and  6),  10  (lanes 3 
and 7), 11 wk (lanes 4and 8), 
and 38 wk (lanes 5 and 9) of 
pregnancy  were  hybridized 
with  a  human  P-cadherin 
probe.  Lanes 6-9 show lanes 
2-5 after exposure periods ten 
times  longer  than  those  for 
lanes 1-5. (b) The same filter 
as that in (a) was rehybridized 
with  a  mouse  E-cadherin 
probe.  Positions  of 28S  and 
18S  ribosomal  RNAs  are 
marked. 
coexpressed  (Fig.  6).  P-cadherin  mRNA  was  strongly  ex- 
pressed in mouse placenta throughout pregnancy, and the ex- 
pression level of P-cadherin mRNA seemed to be somewhat 
stronger than that of E-cadherin mRNA, corresponding well 
with  the previous  immunohistochemical  data  (16). 
Transfection into NIH3T3 Cells 
Human  P-cadherin  cDNA  placed  downstream  from  the 
chicken/~ actin promoter was introduced  into NIH3T3 cells 
by cotransfection with an expression vector p/~act-hP, which 
covers the entire coding region of hhP23 cDNA, and pSTneoB, 
which carries a (3418-resistant gene. After "~2 wk of incuba- 
tion in the presence of G418, more than one hundred colonies 
appeared, and 24 colonies were picked up. Of these, 22 clones 
reacted  with mAb NCC-CAD-299  immunocytochemically, 
and several positive clones were recloned. Figs. 7 and 8 show 
the  reactivity  of one  transfectant,  designated  PN3-5,  with 
mAb NCC-CAD-299 on immunocytochemistry and Western 
blot analysis, respectively. The molecule recognized by mAb 
NCC-CAD-299 was not identified in parental NIH3T3 cells, 
but it was expressed at the cell-cell border as well as in the 
cytoplasm of PN3-5  ceils at the same size as that in A-431 
cells. In addition,  PN3-5 cells appeared to adhere to one an- 
other  more  tightly  than  NIH3T3  cells,  and  they  were  dis- 
sociated by mAb NCC-CAD-299 (Fig. 9), indicating that the 
cadherin  molecule  expressed  at the cell-cell  border of the 
transfectants  was functional  and that the molecule detected 
by mAb NCC-CAD-299  is human  P-cadherin. 
Discussion 
P-cadherin  is  a  subclass  of the  cadherin  family  originally 
identified  in mouse placental  tissues,  where its localization 
suggests a  function  of connecting  the embryo to the uterus 
(16).  In contrast,  our previous immunohistochemical  study 
suggested  that  the  cadherin  that  plays  the  leading  role  in 
cell-cell adhesion in human placental tissue is not the P- but 
the E- type (20). In this study, we cloned and sequenced hu- 
man  P-cadherin  cDNA,  and  investigated  the  RNA  expres- 
sion of both cadherin  types in mouse and human  placental 
tissues. 
A  cDNA clone,  )~hP23,  covering the entire open reading 
Figure 6.  Northern  blot analysis of poly(A)  ÷ 
RNAs isolated from mouse placenta. (a) POly- 
(A)+RNAs  from fetectomied ICR mouse uter- 
us at  10.5 d of pregnancy (lane 1) and mouse 
placenta at  12.5  (lane 2),  14.5  (lane 3),  and 
16.5 d  (lane 4) of pregnancy were hybridized 
with a mouse P-cadherin probe. (b) The same 
filter as that in a was rehybridized with a mouse 
E-cadherin probe.  The filter was exposed for 
5 h in both a and b. Positions of 28S and  18S 
ribosomal RNAs are marked. 
Shiraoyama et al. Human P-Cadherin  1791 Figure  7. Immunocytochemistry of NIH3T3 cells and transfectant PN3-5 cells. NIH3T3 cells (a) and PN3-5 cells (b) were stained by mAb 
NCC-CAD-299 using biotinylated anti-mouse IgG and avidin-biotin-peroxidase complex, and counterstained with hematoxylin.  Positive 
staining at the cell-cell border of PN3-5 cells, arrowheads.  Bar, 50 #m. 
frame of human  P-cadherin,  was  isolated  by  screening  a 
)~gtl0 cDNA library constructed from A-431 poly(A)+RNA 
with a mouse P-cadherin cDNA probe under stringent condi- 
tions of hybridization. This cDNA consists of 3,171 nucleo- 
tides, and contains an open reading frame encoding a poly- 
peptide  of  829  amino  acids.  The  deduced  amino  acid 
sequence of this protein showed that it is an integral mem- 
brane  protein  with  structural  properties  common  to  the 
cadherin  family.  Comparison of the primary structure be- 
tween this protein and other cadherins  revealed a  striking 
homology  with  mouse  P-cadherin,  indicating  that  ),hP23 
cDNA encodes a human counterpart of mouse P-cadherin. 
The sequence of human P-cadherin provides further infor- 
mation on the  evolutionary conservation of each cadherin 
Figure  8.  Western blot analy- 
sis  of  human  P-cadherin  in 
A-431 cells (lane 1), NIH3T3 
cells (lane 2), and transfectant 
PN3-5 cells (lane 3). Cell ly- 
sates  were  loaded  at  100  #g 
protein/lane,  separated  on 
7.5 % polyacrylamide gel, and 
transferred  onto  a  durapore 
membrane  (Nihon  Millipore 
Kogyo, Yonezawa,  Japan). The 
membrane  was  stained  by 
mAb  NCC-CAD-299  using 
peroxidase-conjugated  anti- 
mouse IgG (Cappel Laborato- 
ries, Malvern, PA). The lower 
bands in lanes 1 and 3 proba- 
bly indicate degradation of hu- 
man P-cadherin. Bars indicate 
mobilities  of molecular  mass 
markers in kilodaltons. 
subclass. The amino acid sequences of mouse P- and E-cad- 
herin are only 58% identical (17), whereas the degree of ho- 
mology between mouse and human P-cadherin is 87 %. In the 
restricted amino acid sequences, human uvomorulin (cell- 
CAM  120/80)  is  89%  and  67%  homologous with mouse 
E-cadherin  and human P-cadherin,  respectively. However, 
between greatly diversified species, the degree of similarity 
in  the  same subclass is quite low:  chicken L-CAM shows 
only 65 % homology with mouse E-cadherin. It is known that 
the amino acid sequences of cadherins among different sub- 
classes and species are most conserved in the intracellular 
domain (22) and that the interaction between cadherins and 
the cytoskeleton must be critical for the cell-cell binding func- 
tion of cadherins (7,  14).  Human P-cadherin and other cad- 
herin molecules all end in a hydrophilic and highly conserved 
sequence,  Arg-Phe-Lys-Lys-Leu-Ala-(Asp/Glu)-(Met/Leu)- 
Tyr-Gly-Gly-Gly-(Glu/-)-Asp-Asp-(-/Asp). It  is  conceivable 
that this sequence may be involved in the binding of cadherins 
to some cytoskeletal components, which may support the ter- 
tiary structure of the extracellular domain necessary for the 
homophilic  binding  of cadherins.  Analyses of the  primary 
structure of cadherins have not provided any clear answer to 
the question of which sequences in the extracellular domain 
are responsible for the homophilic and subclass-specific bind- 
ing of cadherins. However, some clue to the mechanism may 
be obtained in the near future by experiments using artificially 
designed mutant cadherin molecules. 
On  Northern  blot  analysis,  the  amount  of  P-cadherin 
mRNA in haman placenta was very low,  in contrast to the 
presence of large amounts  of P-cadherin mRNA in  mouse 
placenta throughout pregnancy.  On the other hand, E-cadherin 
mRNA was definitely  present in  human placental  tissues. 
These results correspond well to the previous immunohisto- 
chemical findings  (20).  The possibility that hhP23  cDNA 
encodes a P-related cadherin distinct from authentic P-cad- 
herin, which is as strongly expressed in human placenta as 
The Journal of Cell Biology, Volume  109, 1989  1792 Figure 9. Phase-contrast micrographs of transfectant PN3-5 cells; b shows the same field as a at 4 h after addition ofmAb NCC-CAD-299. 
Bar, 100/zm. 
it is in mouse,  is thus very unlikely. If this were the case, 
Northern blot analysis of human placental RNAs would have 
revealed the authentic P-cadherin mRNA as a stronger band 
distinct from the '~3.2-kb band. However, no such band was 
ever detected upon human placental RNA blotting even when 
hybridized with mouse P-cadherin cDNA at low stringency 
(data not shown). 
The cloning of human P-cadherin cDNA enabled us to in- 
troduce the cDNA exogenously into NIH3T3 cells. The trans- 
fectants expressing ectopic human P-cadherin acquired the 
enhanced cell-cell binding ability mediated by this molecule, 
providing direct evidence that human P-cadherin is involved 
in cell-cell adhesion. Furthermore, the immunoreactivity of 
mAb NCC-CAD-299 with the transfectants showed that the 
molecule identified by the  mAb  was  undoubtedly human 
P-cadherin. 
Recently, the expression pattern of P- and E-cadherin in 
mouse tissues during the perimplantation period was reported 
in detail (9). According to that study, P-cadherin is first ex- 
pressed on differentiated tropbectoderm cells and decidual 
cells on day 5 of pregnancy and appears to be used for con- 
nection of embryonal tissues to maternal decidual cells. How- 
ever, in human placental tissues both embryonal cytotropho- 
blast cells and maternal decidual cells express only E-cadherin 
and not P-cadherin after 6 wk of pregnancy (20). The finding 
that the main cadherin subclass in placental tissues may dif- 
fer between human and mouse is very surprising. However, 
we cannot conclude that P-cadherin is not involved in human 
embryogenesis, since it is  not possible to examine human 
placental tissues just after implantation. Three possible pat- 
terns of cadherin expression in human placental tissues are 
conceivable: (a) initial coexpression of P- and E-cadherin as 
in the basal layers of stratified epithelia, and cessation of P-cad- 
herin expression in placental tissues as in the upper layers 
of stratified epithelia (20); (b) strong expression of P-cadherin 
even in human placental tissues at a very early stage of preg- 
nancy, as is the case in mouse, with E-cadherin soon taking 
its place.  (c) Connection of the embryo to the uterus only 
by E-cadherin.  The faint expression of human P-cadherin 
mRNA in early-stage placenta may support the first or sec- 
ond possibility. However, the main cadherin type responsible 
for human placental structures, at least from the middle to 
late stage of pregnancy, would be E. 
Our previous study showed that the localization of human 
P-cadherin in  normal tissues  is  extremely restricted (20). 
However, all of the forty lung tumors examined in that study 
expressed P-cadherin. Recently, we found immunohistochem- 
ical expression of P-cadherin in some carcinoma cells, the 
normal counterparts of which do not express P-cadherin (Shi- 
moyama, Y., T. Yoshida, M. Terada, Y. Shimosato, O. Abe, 
and S. Hirohashi, unpublished data). This suggests that some 
regulatory system suppressing the expression of the human 
P-cadherin gene in normal epithelia is lost in the process of 
carcinogenesis. The nature of this regulatory mechanism, the 
reason for its loss in carcinogenesis, and how the newly ac- 
quired P-cadherin affects the biological behavior of  carcinoma 
are aspects that remain to be investigated. 
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